Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Traditionally GLP-1(9-36) was considered inactive, however more recent studies indicate that GLP-1(9-36) can contribute to inhibiting glucagon secretion by inhibiting voltage-gated calcium channels through a GPCR mechanism, an effect which reduces the number of glucagon containing vesicles that are available for exocytosis, thereby contributing the the decrease in glucagon secretion (Figure 1)(Zheng et al, 2024)
For those who need medical assistance with appetite regulation and metabolic function, bmiMD makes more sense
Eating meals at regular intervals throughout the day, ideally aligned with your medications effects, can reduce blood sugar fluctuations and prevent insulin resistance
IGF1-LR3 targets insulin receptors and stimulates glucose uptake inside body cells, similar to all other analogs
Common Feedback Patients commonly report increased energy levels, reduced cravings, and overall improved wellbeing
